Max Mamonkin
@maxmamonkin
Engineering CART for cancer and alloimmunity. Translating to Phase I clinical trials @cagthouston @bcmhouston
ID: 856179633686970368
https://www.bcm.edu/people-search/maksim-mamonkin-26041 23-04-2017 16:15:06
491 Tweet
1,1K Followers
289 Following
Safety and anti-tumor activity of autologous Her2 CART in sarcoma. Congratulations Nabil, Meena and the extended team Center for Cell and Gene Therapy and beyond nature.com/articles/s4301…